IWA
ABBV icon

Intercontinental Wealth Advisors’s AbbVie ABBV Stock Holding History

Intercontinental Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$349K Sell
2,590
-475
-15% -$69.7K 0.08% 239
2023
Q1 		$488K Buy
3,065
+216
+8% +$33K 0.12% 195
2022
Q4 		$460K Buy
2,849
+80
+3% +$12.3K 0.14% 177
2022
Q3 		$372K Sell
2,769
-465
-14% -$66.7K 0.12% 197
2022
Q2 		$495K Buy
3,234
+1
+0% +$153 0.13% 162
2022
Q1 		$524K Sell
3,233
-1,227
-28% -$178K 0.12% 173
2021
Q4 		$604K Sell
4,460
-48
-1% -$5.67K 0.13% 161
2021
Q3 		$486K Buy
4,508
+23
+0.5% +$2.63K 0.11% 167
2021
Q2 		$505K Buy
4,485
+700
+18% +$78.8K 0.1% 178
2021
Q1 		$410K Buy
3,785
+286
+8% +$30.6K 0.09% 181
2020
Q4 		$375K Sell
3,499
-217
-6% -$20.9K 0.09% 175
2020
Q3 		$326K Buy
3,716
+688
+23% +$64.8K 0.1% 151
2020
Q2 		$297K Sell
3,028
-2
-0.1% -$176 0.1% 148
2020
Q1 		$231K Sell
3,030
-615
-17% -$52.4K 0.12% 142
2019
Q4 		$316K Sell
3,645
-1,162
-24% -$96.5K 0.26% 64
2019
Q3 		$364K Sell
4,807
-53
-1% -$3.63K 0.22% 82
2019
Q2 		$353K Buy
4,860
+2,187
+82% +$172K 0.18% 84
2019
Q1 		$215K Buy
2,673
+1
+0% +$82 0.11% 124
2018
Q4 		$246K Sell
2,672
-163
-6% -$14.3K 0.14% 105
2018
Q3 		$268K Buy
2,835
+1
+0% +$95 0.13% 108
2018
Q2 		$263K Sell
2,834
-119
-4% -$11.6K 0.15% 106
2018
Q1 		$279K Buy
2,953
+149
+5% +$16.4K 0.16% 103
2017
Q4 		$271K Buy
2,804
+48
+2% +$4.52K 0.15% 108
2017
Q3 		$245K Sell
2,756
-2,002
-42% -$152K 0.15% 106
2017
Q2 		$345K Sell
4,758
-1,963
-29% -$132K 0.22% 74
2017
Q1 		$438K Sell
6,721
-128
-2% -$8.05K 0.26% 73
2016
Q4 		$429K Sell
6,849
-165
-2% -$10.1K 0.28% 71
2016
Q3 		$442K Sell
7,014
-68
-1% -$4.4K 0.32% 64
2016
Q2 		$438K Sell
7,082
-22
-0.3% -$1.34K 0.32% 66
2016
Q1 		$406K Sell
7,104
-241
-3% -$13.4K 0.31% 72
2015
Q4 		$435K Buy
+7,345
New +$423K 0.3% 76

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Intercontinental Wealth Advisors's ABBV Position: Q2 2023 in Review

Intercontinental Wealth Advisors reduced its AbbVie (ABBV) stake by 15% in Q2 2023, selling an estimated $69.7K and leaving 2,590 shares worth $349K. The position accounts for 0.08% of the portfolio, ranked #239.

Intercontinental Wealth Advisors first reported a position in ABBV in Q4 2015 and has held it in 31 quarters since. The position peaked at $604K in Q4 2021. 3,077 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • Intercontinental Wealth Advisors held 2,590 shares of AbbVie worth $349K as of Q2 2023.
  • Intercontinental Wealth Advisors sold 475 AbbVie shares in Q2 2023, an estimated $69.7K.
  • AbbVie made up 0.08% of Intercontinental Wealth Advisors's portfolio in Q2 2023, its #239 holding.
  • Intercontinental Wealth Advisors first reported a position in AbbVie in Q4 2015 and has held it in 31 quarters since.
  • Intercontinental Wealth Advisors's AbbVie position peaked at $604K in Q4 2021.
  • 3,077 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Intercontinental Wealth Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.